


Ask a doctor about a prescription for MUCOFLUID 200 mg/ml SOLUTION FOR NEBULIZATION AND SOLUTION FOR ENDOTRACHEOPULMONARY INSTILLATION
PACKAGE LEAFLET: INFORMATION FOR THE USER
Mucofluid 200 mg/ml solution for nebulisation and endotracheal instillation
Mesna
Read all of this leaflet carefully before you start using this medicine.
Contents of the pack:
Mucofluid is a mucolytic medicine that binds to certain proteins in mucus fragments and dissolves them, facilitating their elimination.
Via nebulisation, it is used in:
Via endotracheal instillation, it is used:
in bronchoscopy, to ensure better visibility of the areas to be examined.
Do not use Mucofluid
Take special care with Mucofluid
Using other medicines
Tell your doctor or pharmacist if you are using or have recently used any other medicines, including those obtained without a prescription.
Mucofluid can be used simultaneously with other medicines, such as antibiotics (to treat infections), bronchodilators (to treat respiratory disorders of an asthmatic type), corticosteroids (to treat inflammatory processes), and anaesthetics when these are administered intravenously.
It is recommended not to mix Mucofluid in the same solution with aminoglycosides (streptomycin, kanamycin, neomycin, gentamicin), as these are inactivated. However, there is no problem with the use of all these antibiotics via the systemic route and Mucofluid via local application.
Due to physicochemical incompatibility, it is recommended not to mix Mucofluid in the same solution with:
If you undergo a urine analysis, false positive results may appear in the determination of certain components (sulphites or ketones) due to the presence in the urine of certain substances (disulphides or free thiol groups) after administration of mesna.
Pregnancy and breastfeeding
Consult your doctor or pharmacist before using any medicine.
There are insufficient data on the use of mesna in pregnant women.
Mucofluid should not be used during pregnancy except if clearly necessary.
Mucofluid should be avoided during breastfeeding or breastfeeding should be interrupted while receiving treatment with Mucofluid.
Driving and using machines
The influence of Mucofluid on the ability to drive and use machines is nil or insignificant.
Follow the instructions for administration of Mucofluid exactly as indicated by your doctor. Consult your doctor if you have any doubts.
Mucofluid can be administered:
Via nebulisation:The solution can be used undiluted or diluted to an equal extent with distilled water or physiological serum. The solution can be administered preferably with a nasal piece, a mask, or under a chamber.
The usual therapeutic dose is 3 ml (600 mg) to 6 ml (1200 mg) of the undiluted product per day, divided into 3 to 4 administrations per day.
The maximum dose is 24 ml (4.8 g) of undiluted product per day.
Via endotracheal instillation:The solution should be diluted to an equal extent with distilled water or physiological serum. The solution can be administered via an endotracheal tube or tracheotomy cannula.
The usual therapeutic dose is 1 ml or 2 ml of the 10% diluted solution per hour.
The maximum dose is 24 ml (4.8 g) per day.
Treatment should be reduced to the shortest possible period, and if there is no sufficiently rapid improvement, the clinical situation should be reassessed with possible adjustment of treatment. In cystic fibrosis, Mucofluid will be administered according to symptoms.
If you use more Mucofluid than you should:
No cases of overdose have been reported.
After using large volumes of solution and the sudden liquefaction of mucus, partial pulmonary congestion (partial accumulation of fluid in the lungs) may occur, causing transient ventilation disorders. The patient should be strictly monitored and symptomatic treatment should be performed.
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Telephone (91) 562 04 20.
If you forget to use Mucofluid:
Do not use a double dose to make up for forgotten doses.
If you stop using Mucofluid:
Do not stop using Mucofluid without consulting your doctor first.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Mucofluid can cause side effects, although not everybody gets them.
The side effects described with Mucofluid are:
- Chest pain.
- Hypersensitivity (allergy).
- Cough.
- Bronchospasm (contraction of the bronchi, causing narrowing and difficulty breathing).
- Angioneurotic oedema (hives or swelling under the skin).
- Erythematous rash (red skin rash).
- Urticaria (itching).
There is a possibility of bronchospasm, particularly in sensitive asthmatic patients. Vomiting and digestive discomfort caused by excessive fluidification and ingestion of mucus may occur, especially in children.
Sometimes, a sensation of retrosternal burning (central chest area, behind the sternum) may occur with the solution at a concentration of 200 mg/ml (in this case, the solution should be diluted to 100 mg/ml).
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
Keep out of the reach and sight of children.
Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date is the last day of the month indicated.
This medicine does not require any special storage conditions.
As it is a readily oxidisable product, it is preferable to open the ampoule at the time of use. The solution can be used up to 24 hours after opening, stored below 25°C.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Mucofluid
Appearance and packaging of the product
Mucofluid is a clear, colourless solution.
The solution is supplied in a colourless glass ampoule.
Mucofluid is marketed in packs of 6 ampoules of 3 ml of solution.
Marketing authorisation holder and manufacturer
Marketing authorisation holder:
IONFARMA, S.L.
Peru, 228
08020 Barcelona-Spain
Manufacturer:
Laboratorios Reig Jofré, S.A.
Gran Capitan, 10
08970 Sant Joan Despí (Barcelona)
This leaflet was approved in September 2023.
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of MUCOFLUID 200 mg/ml SOLUTION FOR NEBULIZATION AND SOLUTION FOR ENDOTRACHEOPULMONARY INSTILLATION in November, 2025 is around 16.05 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for MUCOFLUID 200 mg/ml SOLUTION FOR NEBULIZATION AND SOLUTION FOR ENDOTRACHEOPULMONARY INSTILLATION – subject to medical assessment and local rules.